Keeping MIGS and Sustained Delivery Meds in the Mix
This activity is supported by an educational grant from AbbVie Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from AbbVie Inc.
Activity Description
Current antiglaucoma medications have demonstrated effectiveness in the treatment of glaucoma, yet adherence to topical glaucoma therapies continues to be an issue especially when multiple therapies are needed to be administered daily. Undertreatment can also be a concern particularly in patients with motor function or coordination difficulties. Available and emerging sustained-release platforms for the delivery of these medications have the potential to address adherence and undertreatment. Moreover, recent surgical approaches for the management of glaucoma, such as minimally invasive glaucoma surgery (MIGS), offer rapid and effective reduction in intraocular pressure while avoiding conjunctival dissection. In this CE monograph, experts in the field will discuss how sustained-release glaucoma medications can improve compliance and treatment efficiency, review minimally invasive glaucoma surgical techniques, and evaluate the effect of incorporating patient preferences into therapeutic decision-making in the management of glaucoma.
Target Audience
The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the management of patients with glaucoma.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Recognize how the use of sustained-release glaucoma medications can improve compliance, increase efficiency of treatment, and provide a pathway for new therapies.
- List minimally invasive glaucoma surgical techniques and technology that can allow for the fine adjustment of therapies as well as for a patient-centric decision-making process.
- Examine the effect of incorporating patient preferences into therapeutic decision-making in the management of glaucoma.
Activity Chair
Inder Paul Singh, MD
President and Head of the Division of Glaucoma and Research
Eye Centers of Racine and Kenosha
Racine, WI
Faculty
Sahar Bedrood, MD, PhD
Glaucoma and Cataract Surgeon
Advanced Vision Care
Adjunct Clinical Assistant Professor
USC Roski Eye Institute
Los Angeles, CA
Monica Ertel, MD, PhD
Assistant Professor of Ophthalmology
University of Colorado
Denver, CO
Medical Writer
Pranali Pathare Mangat, PhD
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, January 31, 2024, to January 30, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
The articles in this monograph were composed by medical writer Pranali Pathare Mangat, PhD, based on the presentations of Drs. Bedrood, Ertel, and Singh during a live/virtual expert panel discussion/satellite symposium held on November 5, 2023. The content of this monograph has been approved by each of the faculty individually as an accurate representation of their presentations..
Activity Chair and Faculty report the following relevant financial relationship(s)
Sahar Bedrood, MD, PhD
Consultant: Allergan, Belkin, BVI, Glaukos, MST Pharma, Ocular Therapeutix, Thea
Speaker Contracted by Ineligible Company: Allergan, Glaukos
Monica Ertel, MD, PhD
Consultant: Allergan, New World Medical, Zeiss
Inder Paul Singh, MD
Consultant: Ace Vision, Alcon, Allergan, Bausch + Lomb, Dompé, Elios Vision, Glaukos, New World Medical, Nova Eye, Rayner, Sight Sciences, Thea, ViaLase, Zeiss
Speaker Contracted by Ineligible Company: Alcon, Allergan, Dompé, Elios Vision, Glaukos, iSTAR, New World Medical, Nova Eye, Sight Sciences, Thea
Independent Research Contractor: Alcon, Allergan, Glaukos, New World Medical
Medical Writer reports the following relevant financial relationship(s)
Pranali Pathare Mangat, PhD
No relevant financial relationships to disclose.
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by getting in touch with our designated copyright agent (as outlined below). To do so, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com